Special Issue on ‘‘Biomarkers for Human Diseases and Translational Medicine”

正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on ‘‘Biomarkers for Human Diseases and Translational Medicine'

<正>The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on “Biomarkers for Human Diseases and Translational Medicine”

正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Spring of 2017)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on "Biomarkers for Human Diseases and Translational Medicine"

正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on “Biomarkers for Human Diseases and Translational Medicine”

正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on “Biomarkers for Human Diseases and Translational Medicine''

<正>The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the Spring of 2017)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,prognosis,and guidance for treatment,and are important tools in translational medicine.     

Special Issue on “Biomarkers for Human Diseases and Translational Medicine”

正The journal Genomics,ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the fall of 2016)on the topic of‘‘Biomarkers for Human Diseases and Translational Medicine’’.In the personalized medicine era,disease biomarkers have potential application in diagnosis,     

Special Issue on‘‘Biomarkers for Diseases’’

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,RNA     

Special Issue on ‘‘Biomarkers for Diseases”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,RNA,protein or metabolites,could gain highly sensitive and specific signals that truly reflect     

Special Issue on ‘‘Big Data and Precision Medicine'

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the spring of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the     

Special Issue on ‘‘Big Data and Precision Medicine”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the spring of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the     

Special Issue on ‘‘Big Data and Precision Medicine'

正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the fall of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.     

Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex

Inflammatory diseases such as inflammatory bowel disease(IBD) require recurrent invasive tests, including blood tests, radiology, and endoscopic evaluation both to diagnose and assess disease activity, and to determine optimal therapeutic strategies. Simple ‘bedside' biomarkers could be used in all phases of patient management to avoid unnecessary investigation and guide further management. The focal adhesion complex(FAC) has been implicated in the pathogenesis of multiple inflammatory diseases, including IBD, rheumatoid arthritis, and multiple sclerosis. Utilizing omics technologies has proven to be an efficient approach to identify biomarkers from within the FAC in the field of cancer medicine. Predictive biomarkers are paving the way for the success of precision medicine for cancer patients, but inflammatory diseases have lagged behind in this respect. This review explores the current status of biomarker prediction for inflammatory diseases from within the FAC using omics technologies and highlights the benefits of future potential biomarker identification approaches.     

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine

Cancer therapy agents have been used extensively as cytotoxic drugs against tissue or organ of a specific type of cancer. With the better understanding of molecular mechanisms underlying carcinogenesis and cellular events during cancer progression and metastasis, it is now possible to use targeted therapy for these molecular events. Targeted therapy is able to identify cancer patients with dissimilar genetic defects at cellular level for the same cancer type and consequently requires individualized approach for treatment. Cancer therapy begins to shift steadily from the traditional approach of ‘‘one regimen for all patients" to a more individualized approach, through which each patient will be treated specifically according to their specific genetic defects. Personalized medicine accordingly requires identification of indicators or markers that guide in the decision making of such therapy to the chosen patients for more effective therapy. Cancer biomarkers are frequently used in clinical practice for diagnosis and prognosis, as well as identification of responsive patients and prediction of treatment response of cancer patient. The rapid breakthrough and development of microarray and sequencing technologies is probably the main tool for paving the way toward ‘‘individualized biomarker-driven cancer therapy" or ‘‘personalized medicine". In this review, we aim to provide an updated knowledge and overview of the current landscape of cancer biomarkers and their role in personalized medicine, emphasizing the impact of genomics on the implementation of new potential targeted therapies and development of novel cancer biomarkers in improving the outcome of cancer therapy.     

Special Issue on“Biomarkers for Diseases”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue(to be published in the winter of 2015)on the topic of‘‘Biomarkers for Diseases’’.As an emerging index,disease biomarkers have demonstrated the potential application in diagnosis and prognosis.The detection of the disease indicators at molecular level,DNA,     

Special Issue on “Big Data and Precision Medicine”

<正>The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the spring of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the     

Special Issue on ‘‘Computational Cardiology'

正We are pleased to announce a special issue on‘‘Computational Cardiology’’of the journal Genomics,ProteomicsBioinformatics(GPB),aiming to provide a platform for high-quality papers focusing on the topic and we invite submissions for this special issue(to be published in the Spring of 2016).Dr.Benjamin Meder(University of Heidelberg and German Center for Cardiovascular Research–DZHK,Germany)and Dr.Andreas Keller(Saarland University,Germany)are Guest Editors of this issue.     

Special Issue on “Big Data and Precision Medicine”

正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the fall of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.     

Special Issue on "Big Data and Precision Medicine"

正The journal Genomics ProteomicsBioinformatics(GPB)is now inviting submissions for a special issue on the topic of‘‘Big Data and Precision Medicine’’to be published in the fall of 2016.For many complex diseases,the traditional‘‘one drug for one disease’’scenario may soon become history.The new concept of‘‘precision medicine’’will heavily rely on the collection of large amount of data from the population as well as patients of specific diseases.     

Special Issue on ‘‘Computational Cardiology'

<正>We are pleased to announce a special issue on‘‘Computational Cardiology’’of the journal Genomics,ProteomicsBioinformatics(GPB),aiming to provide a platform for high-quality papers focusing on the topic and we invite submissions for this special issue(to be published in the Spring of 2016).Dr.Benjamin Meder(University of Heidelberg and German Center for Cardiovascular Research–DZHK,Germany)and Dr.Andreas Keller(Saarland University,Germany)are Guest Editors of this issue.